Showing results (391-400 of 414) with videos related to

Sort By:
Pageof 42
Hepatology (Baltimore, Md.)|September 16, 2020
Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral TherapyAnna S Lok, Robert Perrillo, Christina M Lalama, et al.
Journal of Hepatology|January 22, 2014
Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null respondersAnna S Lok, David F Gardiner, Christophe Hézode, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis CNeal D Freedman, James E Everhart, Karen L Lindsay, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 18, 1999
Stanniocalcin 2: characterization of the protein and its localization to human pancreatic alpha cellsE E Moore, R E Kuestner, D C Conklin, et al.
Radiology|January 24, 2023
Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular CarcinomaTakeshi Yokoo, Nobuaki Masaki, Neehar D Parikh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2018
Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort StudyJessica P Hwang, Anna S Lok, Michael J Fisch, et al.
Hepatology (Baltimore, Md.)|November 4, 2025
AASLD/IDSA Practice Guideline on treatment of chronic hepatitis BMarc G Ghany, Calvin Q Pan, Anna S Lok, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 7, 2018
Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and CirrhosisJoseph K Lim, Ann Marie Liapakis, Mitchell L Shiffman, et al.
Hepatology (Baltimore, Md.)|November 7, 2021
Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohortNorah A Terrault, Abdus S Wahed, Jordan J Feld, et al.
Alimentary Pharmacology & Therapeutics|October 30, 2016
All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET databaseK R Reddy, J K Lim, A Kuo, et al.
Pageof 42